A dynamic susceptibility contrast MRI digital reference object for testing software with leakage correction: Effect of background simulation
- PMID: 34293208
- DOI: 10.1002/mp.15125
A dynamic susceptibility contrast MRI digital reference object for testing software with leakage correction: Effect of background simulation
Abstract
Purpose: Dynamic susceptibility contrast (DSC)-MRI is a perfusion imaging technique from which useful quantitative imaging biomarkers can be derived. Relative cerebral blood volume (rCBV) is such a biomarker commonly used for evaluating brain tumors. To account for the extravasation of contrast agents in tumors, post-processing leakage correction is often applied to improve rCBV accuracy. Digital reference objects (DRO) are ideal for testing the post-processing software, because the biophysical model used to generate the DRO can be matched to the one that the software uses. This study aims to develop DROs to validate the leakage correction of software using Weisskoff model and to examine the effect of background signal time curves that are required by the model.
Methods: Three DROs were generated using the Weisskoff model, each composed of nine foreground lesion objects with combinations of different levels of rCBV and contrast leakage parameter (K2). Three types of background were implemented for these DROs: (1) a multi-compartment brain-like background, (2) a sphere background with a constant signal time curve, and (3) a sphere background with signal time curve identical to that of the brain-like DRO's white matter (WM). The DROs were then analyzed with an FDA-cleared software with and without leakage correction. Leakage correction was tested with and without brain segmentation.
Results: Accuracy of leakage correction was able to be verified using the brain-like phantom and the sphere phantom with WM background. The sphere with constant background did not perform well with leakage correction with or without brain segmentation. The DROs were able to verify that for the particular software tested, leakage correction with brain segmentation achieved the lowest error.
Conclusions: DSC-MRI DROs with biophysical model matched to that of the post-processing software can be well used for the software's validation, provided that the background signals are also properly simulated for generating the reference time curve required by the model. Care needs to be taken to consider the interaction of the design of the DRO with the software's implementation of brain segmentation to extract the reference time curve.
Keywords: DRO; DSC; MRI; digital phantom; digital reference object; dynamic susceptibility contrast; quality assurance.
© 2021 American Association of Physicists in Medicine.
Similar articles
-
Systematic assessment of multi-echo dynamic susceptibility contrast MRI using a digital reference object.Magn Reson Med. 2020 Jan;83(1):109-123. doi: 10.1002/mrm.27914. Epub 2019 Aug 9. Magn Reson Med. 2020. PMID: 31400035 Free PMC article.
-
Is Weisskoff model valid for the correction of contrast agent extravasation with combined T1 and T2* effects in dynamic susceptibility contrast MRI?Med Phys. 2011 Feb;38(2):802-9. doi: 10.1118/1.3534197. Med Phys. 2011. PMID: 21452717
-
Evaluating Multisite rCBV Consistency from DSC-MRI Imaging Protocols and Postprocessing Software Across the NCI Quantitative Imaging Network Sites Using a Digital Reference Object (DRO).Tomography. 2019 Mar;5(1):110-117. doi: 10.18383/j.tom.2018.00041. Tomography. 2019. PMID: 30854448 Free PMC article.
-
Dynamic susceptibility-contrast magnetic resonance imaging with contrast agent leakage correction aids in predicting grade in pediatric brain tumours: a multicenter study.Pediatr Radiol. 2022 May;52(6):1134-1149. doi: 10.1007/s00247-021-05266-7. Epub 2022 Mar 15. Pediatr Radiol. 2022. PMID: 35290489 Free PMC article.
-
Imaging vascular and hemodynamic features of the brain using dynamic susceptibility contrast and dynamic contrast enhanced MRI.Neuroimage. 2019 Feb 15;187:32-55. doi: 10.1016/j.neuroimage.2018.04.069. Epub 2018 May 3. Neuroimage. 2019. PMID: 29729392 Free PMC article.
Cited by
-
A Review on the Use of Imaging Biomarkers in Oncology Clinical Trials: Quality Assurance Strategies for Technical Validation.Tomography. 2023 Oct 17;9(5):1876-1902. doi: 10.3390/tomography9050149. Tomography. 2023. PMID: 37888741 Free PMC article. Review.
References
REFERENCES
-
- Rempp KA, Brix G, Wenz F, Becker CR, Gückel F, Lorenz WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology. 1994;193(3):637-641. https://doi.org/10.1148/radiology.193.3.7972800
-
- Hu LS, Baxter LC, Smith KA, et al. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements. Am J Neuroradiol. 2009;30(3):552-558. https://doi.org/10.3174/ajnr.A1377
-
- Essig M, Nguyen TB, Shiroishi MS, et al. Perfusion MRI: the five most frequently asked clinical questions. AJR Am J Roentgenol. 2013;201(3):W495-W510. https://doi.org/10.2214/AJR.12.9544
-
- Boxerman JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. Am J Neuroradiol. 2006;27(4):859-867.
-
- Hu LS, Kelm Z, Korfiatis P, et al. Impact of software modeling on the accuracy of perfusion MRI in glioma. Am J Neuroradiol. 2015;36(12):2242-2249. https://doi.org/10.3174/ajnr.A4451
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical